Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials-Reference-Cited by-同舟云学术

Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials

Published:2018-02-06 Issue:2 Volume:13 Page:e0192464
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Xuan^ORCID,Dai Danian,Chen Bo,Tang Hailin,Xie Xiaoming,Wei Weidong

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference74 articles.

1. The phosphoinositide 3-kinase pathway;LC Cantley;Science (New York, NY),2002

2. The PI3K Pathway in Human Disease;DA Fruman;Cell,2017

3. Regulation of mTORC1 by PI3K signaling;CC Dibble;Trends in cell biology,2015

4. mTOR Signaling in Growth, Metabolism, and Disease;RA Saxton;Cell,2017

5. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women;N Maruyama;Clinical cancer research: an official journal of the American Association for Cancer Research,2007

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer;Clinical Breast Cancer;2024-08

2. Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer;Chemico-Biological Interactions;2024-06

3. PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities;Pharmacological Research;2024-04

4. Assessing robustness to worst case publication bias using a simple subset meta-analysis;BMJ;2024-03-15

5. Urothelium-Specific Expression of Mutationally Activated Pik3ca Initiates Early Lesions of Noninvasive Bladder Cancer;The American Journal of Pathology;2023-12